3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
6
Neoplasms
1
Mesothelioma, Malignant
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Interventions
Rituximab
23
Cyclophosphamide
21
Prednisone
16
Doxorubicin
14
Magnetic Resonance Spectroscopy
13
Vincristine
11
Specimen Handling
11
Lenalidomide
10
ibrutinib
8
Biopsy
8
obinutuzumab
7
polatuzumab vedotin
6
glofitamab
6
Gemcitabine
6
Oxaliplatin
5
venetoclax
4
prednylidene
4
pembrolizumab
4
fludarabine
4
deltacortene
4
Prednisolone
4
Etoposide
4
Dexamethasone
4
Cyclosporine
4
CT-P10
4
fludarabine phosphate
3
Whole-Body Irradiation
3
R-CHOP protocol
3
Nivolumab
3
Mycophenolic Acid
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large B-Cell, Diffuse
×
Brentuximab Vedotin
×
30 days
×
Clear all
No trials found.